Science 37 Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 460

Employees

  • Stock Symbol
  • SNCE

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.24
  • (As of Wednesday Closing)

Science 37 General Information

Description

Science 37 Holdings Inc is engaged in the development of new and innovative treatments that impact patient lives. It enables universal access to patients and providers for clinical trials. Its Operating System is fused with networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Stock Exchange
NAS
Primary Office
  • 600 Corporate Pointe
  • Suite 320
  • Culver City, CA 90230
  • United States
+1 (984) 000-0000

Science 37 Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Science 37 Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.24 $0.19 - $0.70 $28.7M 119M 207K -$1.07

Science 37 Financials Summary

In Thousands,
USD
TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV (17,130) (80,313) 1,430,398
Revenue 60,261 70,147 59,597 23,704
EBITDA (122,268) (34,831) (86,534) (27,304)
Net Income (124,651) (50,988) (94,331) (31,674)
Total Assets 75,727 126,448 260,798 57,031
Total Debt 581 1,322 2,442 2,481
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Science 37 Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Science 37‘s full profile, request access.

Request a free trial

Science 37 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Science 37‘s full profile, request access.

Request a free trial

Science 37 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Science 37 Holdings Inc is engaged in the development of new and innovative treatments that impact patient lives. It ena
Enterprise Systems (Healthcare)
Culver City, CA
460 As of 2022
00000
000000000 00000

000000

nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
00000 0000000000 000
Palo Alto, CA
000 As of 0000
00000
00000000000 00000

000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
0000000 0000000 0000
Austin, TX
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Science 37 Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medable Venture Capital-Backed Palo Alto, CA 000 00000 00000000000 00000
000000 000000 0000 Venture Capital-Backed Austin, TX 000 00000 000000000 00000
00000 000000 Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
00 0000000000 Venture Capital-Backed Solana Beach, CA 00 000.00 00000000000 000.00
0000000 000000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Science 37 Executive Team (38)

Name Title Board Seat Contact Info
David Coman Chief Executive Officer & Board Member
Mike Zaranek Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Christine Pellizzari JD Executive & Chief Legal Officer, Legal
Tyler Van Horn Vice President & Chief of Staff & Corporate Strategy
Michael Shipton Chief Commercial Officer
You’re viewing 5 of 38 executive team members. Get the full list »

Science 37 Board Members (14)

Name Representing Role Since
Bhooshi De Silva Pharmaceutical Product Development Board Member 000 0000
Bhooshitha De Silva Science 37 Board Member 000 0000
David Coman Science 37 Chief Executive Officer & Board Member 000 0000
Emily Rollins Science 37 Board Member 000 0000
Itai Danovitch MD Science 37 Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Science 37 Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Science 37 Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Science 37‘s full profile, request access.

Request a free trial

Science 37 Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vault Health(life science platform) 02-Feb-2023 000000000 Laboratory Services (Healthcare) 00000 000
LifeSci Acquisition II 06-Oct-2021 Merger/Acquisition 00.000 Special Purpose Acquisition Company (SPAC) 00000 000
To view Science 37’s complete investments and acquisitions history, request access »

Science 37 ESG

Risk Overview

Risk Rating

Updated June, 21, 2023

23.99 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,708

Rank

00.00

Percentile

Commercial Services

Industry

00 of 452

Rank

00.00

Percentile

Business Support Services

Subindustry

00 of 174

Rank

00.00

Percentile

To view Science 37’s complete esg history, request access »